|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:PRCC-TMED5 (FusionGDB2 ID:67986) |
Fusion Gene Summary for PRCC-TMED5 |
Fusion gene summary |
Fusion gene information | Fusion gene name: PRCC-TMED5 | Fusion gene ID: 67986 | Hgene | Tgene | Gene symbol | PRCC | TMED5 | Gene ID | 5546 | 50999 |
Gene name | proline rich mitotic checkpoint control factor | transmembrane p24 trafficking protein 5 | |
Synonyms | RCCP1|TPRC | CGI-100|p24g2|p28 | |
Cytomap | 1q23.1 | 1p22.1 | |
Type of gene | protein-coding | protein-coding | |
Description | proline-rich protein PRCCPRCC, proline rich mitotic checkpoint control factorpapillary renal cell carcinoma (translocation-associated)papillary renal cell carcinoma translocation-associated gene protein | transmembrane emp24 domain-containing protein 5p24 family protein gamma-2p24gamma2transmembrane emp24 protein transport domain containing 5 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000271526, ENST00000353233, ENST00000491853, | ENST00000370282, ENST00000483033, ENST00000479918, ENST00000370280, | |
Fusion gene scores | * DoF score | 12 X 6 X 10=720 | 5 X 3 X 3=45 |
# samples | 14 | 5 | |
** MAII score | log2(14/720*10)=-2.36257007938471 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/45*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: PRCC [Title/Abstract] AND TMED5 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | PRCC(156738031)-TMED5(93625783), # samples:4 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | PRCC | GO:0007093 | mitotic cell cycle checkpoint | 11717438 |
Fusion gene breakpoints across PRCC (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across TMED5 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | THCA | TCGA-ET-A40S-01A | PRCC | chr1 | 156738031 | + | TMED5 | chr1 | 93625783 | - |
ChimerDB4 | THCA | TCGA-ET-A40S | PRCC | chr1 | 156738031 | + | TMED5 | chr1 | 93625783 | - |
ChimerDB4 | THCA | TCGA-ET-A40S-01A | PRCC | chr1 | 156738031 | + | TMED5 | chr1 | 93625783 | - |
ChimerDB4 | THCA | TCGA-ET-A40S-01A | PRCC | chr1 | 156738031 | - | TMED5 | chr1 | 93625783 | - |
Top |
Fusion Gene ORF analysis for PRCC-TMED5 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000271526 | ENST00000370282 | PRCC | chr1 | 156738031 | + | TMED5 | chr1 | 93625783 | - |
5CDS-5UTR | ENST00000271526 | ENST00000483033 | PRCC | chr1 | 156738031 | + | TMED5 | chr1 | 93625783 | - |
5CDS-5UTR | ENST00000271526 | ENST00000479918 | PRCC | chr1 | 156738031 | + | TMED5 | chr1 | 93625783 | - |
5CDS-5UTR | ENST00000271526 | ENST00000370280 | PRCC | chr1 | 156738031 | + | TMED5 | chr1 | 93625783 | - |
In-frame | ENST00000353233 | ENST00000370282 | PRCC | chr1 | 156738031 | + | TMED5 | chr1 | 93625783 | - |
5CDS-5UTR | ENST00000353233 | ENST00000483033 | PRCC | chr1 | 156738031 | + | TMED5 | chr1 | 93625783 | - |
5CDS-5UTR | ENST00000353233 | ENST00000479918 | PRCC | chr1 | 156738031 | + | TMED5 | chr1 | 93625783 | - |
5CDS-5UTR | ENST00000353233 | ENST00000370280 | PRCC | chr1 | 156738031 | + | TMED5 | chr1 | 93625783 | - |
intron-3CDS | ENST00000491853 | ENST00000370282 | PRCC | chr1 | 156738031 | + | TMED5 | chr1 | 93625783 | - |
intron-5UTR | ENST00000491853 | ENST00000483033 | PRCC | chr1 | 156738031 | + | TMED5 | chr1 | 93625783 | - |
intron-5UTR | ENST00000491853 | ENST00000479918 | PRCC | chr1 | 156738031 | + | TMED5 | chr1 | 93625783 | - |
intron-5UTR | ENST00000491853 | ENST00000370280 | PRCC | chr1 | 156738031 | + | TMED5 | chr1 | 93625783 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000271526 | PRCC | chr1 | 156738031 | + | ENST00000370282 | TMED5 | chr1 | 93625783 | - | 6169 | 740 | 272 | 1240 | 322 |
ENST00000353233 | PRCC | chr1 | 156738031 | + | ENST00000370282 | TMED5 | chr1 | 93625783 | - | 6115 | 686 | 218 | 1186 | 322 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000271526 | ENST00000370282 | PRCC | chr1 | 156738031 | + | TMED5 | chr1 | 93625783 | - | 0.000565185 | 0.99943477 |
ENST00000353233 | ENST00000370282 | PRCC | chr1 | 156738031 | + | TMED5 | chr1 | 93625783 | - | 0.000556819 | 0.9994431 |
Top |
Fusion Genomic Features for PRCC-TMED5 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for PRCC-TMED5 |
Go to FGviewer for the breakpoints of chr1:156738031-chr1:93625783 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PRCC | chr1:156738031 | chr1:93625783 | ENST00000271526 | + | 1 | 7 | 18_25 | 156.0 | 492.0 | Compositional bias | Note=Poly-Glu |
Hgene | PRCC | chr1:156738031 | chr1:93625783 | ENST00000271526 | + | 1 | 7 | 52_55 | 156.0 | 492.0 | Compositional bias | Note=Poly-Pro |
Hgene | PRCC | chr1:156738031 | chr1:93625783 | ENST00000271526 | + | 1 | 7 | 79_84 | 156.0 | 492.0 | Compositional bias | Note=Poly-Pro |
Hgene | PRCC | chr1:156738031 | chr1:93625783 | ENST00000271526 | + | 1 | 7 | 91_94 | 156.0 | 492.0 | Compositional bias | Note=Poly-Pro |
Tgene | TMED5 | chr1:156738031 | chr1:93625783 | ENST00000370282 | 0 | 4 | 218_229 | 63.0 | 230.0 | Topological domain | Cytoplasmic | |
Tgene | TMED5 | chr1:156738031 | chr1:93625783 | ENST00000479918 | 0 | 5 | 218_229 | 63.0 | 194.0 | Topological domain | Cytoplasmic | |
Tgene | TMED5 | chr1:156738031 | chr1:93625783 | ENST00000370282 | 0 | 4 | 197_217 | 63.0 | 230.0 | Transmembrane | Helical | |
Tgene | TMED5 | chr1:156738031 | chr1:93625783 | ENST00000479918 | 0 | 5 | 197_217 | 63.0 | 194.0 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PRCC | chr1:156738031 | chr1:93625783 | ENST00000271526 | + | 1 | 7 | 235_239 | 156.0 | 492.0 | Compositional bias | Note=Poly-Thr |
Tgene | TMED5 | chr1:156738031 | chr1:93625783 | ENST00000370282 | 0 | 4 | 45_126 | 63.0 | 230.0 | Domain | GOLD | |
Tgene | TMED5 | chr1:156738031 | chr1:93625783 | ENST00000479918 | 0 | 5 | 45_126 | 63.0 | 194.0 | Domain | GOLD | |
Tgene | TMED5 | chr1:156738031 | chr1:93625783 | ENST00000370282 | 0 | 4 | 28_196 | 63.0 | 230.0 | Topological domain | Lumenal | |
Tgene | TMED5 | chr1:156738031 | chr1:93625783 | ENST00000479918 | 0 | 5 | 28_196 | 63.0 | 194.0 | Topological domain | Lumenal |
Top |
Fusion Gene Sequence for PRCC-TMED5 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000271526_ENST00000370282_TCGA-ET-A40S-01A_PRCC_chr1_156738031_+_TMED5_chr1_93625783_length(transcript)=6169nt_BP=740nt ATTGGTGAGGCAAGGAGGAGGCGGAGTGACTCGGCGGCCATTAGCTGTGTGTAGTTGCCCGGGACTAGGAGCTTAAGTGAAGAGGTACGC CTTGTTCGGTGGAAATCAGCCGTAGCCATGAGTTTCTGCCGGGGCTAGCCCTAGAGTACGGAGCAGGCGGACTTTTCGGTTCCCCGCCCC GCCAGGTGGCGGGGCCTACTAGGCCTCCGGGCATCCCCGGTCTCAAGTAGGCCTCATCTGCCGGCAAGGGCGCCCGAAACGCGGGAGGCG CCATGTCGCTGGTTGCTTACGCCAGCAGCGATGAGAGCGAGCCGGATGAGGCTGAGCCCGAGCCGGAGGAAGAGGAGGCGGTGGCTCCTA CATCTGGGCCCGCTTTAGGGGGCTTGTTCGCTTCTCTCCCTGCGCCCAAGGGTCCGGCCTTGCTGCCTCCGCCCCCTCAGATGCTGGCGC CAGCCTTTCCCCCGCCGCTGTTGCTTCCCCCACCCACCGGAGACCCCAGGCTTCAGCCTCCTCCCCCCTTGCCCTTCGGCCTGGGAGGCT TCCCCCCACCTCCAGGCGTGAGCCCGGCTGAAGCGGCGGGAGTTGGGGAGGGACTGGGATTGGGGTTGCCCTCGCCCCGAGGCCCTGGCC TCAATCTGCCCCCTCCAATTGGCGGTGCCGGTCCCCCGCTGGGGCTTCCCAAGCCAAAGAAGAGGAAAGAGCCCGTGAAGATCGCGGCGC CGGAGTTGCATAAGGGAGATGTTTTAGATGGAGCAGGATTAGATATTGATTTCCATCTTGCCTCTCCAGAAGGCAAAACCTTAGTTTTTG AACAAAGAAAATCAGATGGAGTTCACACTGTAGAGACTGAAGTTGGTGATTACATGTTCTGCTTTGACAATACATTCAGCACCATTTCTG AGAAGGTGATTTTCTTTGAATTAATCCTGGATAATATGGGAGAACAGGCACAAGAACAAGAAGATTGGAAGAAATATATTACTGGCACAG ATATATTGGATATGAAACTGGAAGACATCCTGGAATCCATCAACAGCATCAAGTCCAGACTAAGCAAAAGTGGGCACATACAAACTCTGC TTAGAGCATTTGAAGCTCGTGATCGAAACATACAAGAAAGCAACTTTGATAGAGTCAATTTCTGGTCTATGGTTAATTTAGTGGTCATGG TGGTGGTGTCAGCCATTCAAGTTTATATGCTGAAGAGTCTGTTTGAAGATAAGAGGAAAAGTAGAACTTAAAACTCCAAACTAGAGTACG TAACATTGAAAAATGAGGCATAAAAATGCAATAAACTGTTACAGTCAAGACCATTAATGGTCTTCTCCAAAATATTTTGAGATATAAAAG TAGGAAACAGGTATAATTTTAATGTGAAAATTAAGTCTTCACTTTCTGTGCAAGTAATCCTGCTGATCCAGTTGTACTTAAGTGTGTAAC AGGAATATTTTGCAGAATATAGGTTTAACTGAATGAAGCCATATTAATAACTGCATTTTCCTAACTTTGAAAAATTTTGCAAATGTCTTA GGTGATTTAAATAAATGAGTATTGGGCCTAATTGCAACACCAGTCTGTTTTTAACAGGTTCTATTACCCAGAACTTTTTTGTAAATGCGG CAGTTACAAATTAACTGTGGAAGTTTTCAGTTTTAAGTTATAAATCACCTGAGAATTACCTAATGATGGATTGAATAAATCTTTAGACTA CAAAAGCCCAACTTTTCTCTATTTACATATGCATCTCTCCTATAATGTAAATAGAATAATAGCTTTGAAATACAATTAGGTTTTTGAGAT TTTTATAACCAAATACATTTCAGTGTAACATATTAGCAGAAAGCATTAGTCTTTGTACTTTGCTTACATTCCCAAAAGCTGACATTTTCA CGATTCTTAAAAACACAAAGTTACACTTACTAAAATTAGGACATGTTTTCTCTTTGAAATGAAGAATATAGTTTAAAAGCTTCCTCCTCC ATAGGGACACATTTTCTCTAACCCTTAACTAAAGTGTAGGATTTTAAAATTAAATGTGAGGTAAAATAAGTTTATTTTTAATAGTATCTG TCAAGTTAATATCTGTCAACAGTTAATAATCATGTTATGTTAATTTTAACATGATTGCTGACTTGGATAATTCATTATTACCAGCAGTTA TGAAGGAAATATTGCTAAAATGATCTGGGCCTACCATAAATAAATATCTCCTTTTCTGAGCTCTAAGAATTATCAGAAACAGGAAAGAAT TTAGAAAAACTTGAGAAAACCTAATCCAAAATAAAATTCACTTAAGTAGAACTATAAATAAATATCTAGAATCTGACTGGCTCATCATGA CATCCTACTCATAACATAAATCAAAGGAGATGATTAATTTCCAGTTAGCTGGAAGAAACTTTGGCTGTAGGTTTTTATTTTCTACAAGAA TTCTGGTTTGAATTATTTTTGTAAGCAGGTACATTTTATAAAATGTAAGCCCTACTGTAAGGTTTAGCACTGGGTGTACATATTTATTAA AAATTTTTATTATAACAACTTTTATTAAAATGGCCTTTCTGAACACTTTATTTATTGATGTTGAAGTAAGGATTAGAAACATAGACTCCC AAGTTTTAAACACCTAAATGTGAATAACCCATATATACAACAAAGTTTCTGCCATCTAGCTTTTTGAAGTCTATGGGGGTCTTACTCAAG TACTAGTAATTTAACTTCATCATGAATGAACTATAATTTTTAAGTTATGCCCATTTATAACGTTGTTTATGACTACATTGTGAGTTAGAA ACAAACTTAAAATTTGGGGTATAGAACCCCTCAACAGGTTAGTAATGCTGGAATTCTTGATGAGCAATAATGATAACCAGAGAGTGATTT CATTTACACTCATAGTAGTATAAAAAGAGATACATTTCCCTCTTAGGCCCCTGGGAGAAGAGCAGCTTAGATTTCCCTACTGGCAAGGTT TTTAAAAATGAGGTAAATGCCGTATATGATCAATTACCTTAATTGGCCAAGAAAATGCTTCAGGTGTCTAGGGGTATCCTCTGCAACACT TGCAGAACAAAGGTCAATAAGATCCTTGCCTATGAATACCCCTCCCTTTTGCGCTGTTAAATTTGCAATGAGAAGCAAATTTACAGTACC ATAACTAATAAAGCAGGGTACAGATATAAACTACTGCATCTTTTCTATAAAACTGTGATTAAGAATTCTACCTCTCCTGTATGGCTGTTA CTGTACTGTACTCTCTGACTCCTTACCTAACAATGAATTTGTTACATAATCTTCTACATGTATGATTTGTGCCACTGATCTTAAACCTAT GATTCAGTAACTTCTTACCATATAAAAACGATAATTGCTTTATTTGGAAAAGAATTTAGGAATACTAAGGACAATTATTTTTATAGACAA AGTAAAAAGACAGATATTTAAGAGGCATAACCAAAAAAGCAAAACTTGTAAACAGAGTAAAAATCTTTAATATTTCTAAAGACATACTGT TTATCTGCTTCATATGCTTTTTTTAATTTCACTATTCCATTTCTAAATTAAAGTTATGCTAAATTGAGTAAGCTGTTTATCACTTAACAG CTCATTTTGTCTTTTTCAATATACAAATTTTAAAAATACTACAATATTTAACTAAGGCCCAACCGATTTCCATAATGTAGCAGTTACCGT GTTCACCTCACACTAAGGCCTAGAGTTTGCTCTGATATGCATTTGGATGATTAATGTTATGCTGTTCTTTCATGTGAATGTCAAGACATG GAGGGTGTTTGTAATTTTATGGTAAAATTAATCCTTCTTACACATAATGGTGTCTTAAAATTGACAAAAAATGAGCACTTACAATTGTAT GTCTCCTCAAATGAAAATTCTTTATCTGAAATTTTAAAAGACATTGATTCCACATGTAAGGATTTTTCATCTGAAGTACAATAATGCACA ATCAGTGTTGCTCAAACTGCTTTATACTTATAAACAGCCATCTTAAATAAGCAACGTATTGTGAGTACTGATATGTATATAATAAAAATT ATCAAAGAAAATTAACTGCCAGTCATTTGTAAATGCTGTCTACTCCTGAAAGCCTTCCTTCATCTCTATTTAGTTAATAATGTGCTCTCT CCTCCTGTTTTGAAACCCCATAGCTCTCTACACCTCTTATTGTACATCACTCTACTTTGCATTGGAGTTCTGTTTCTATATGTACTTATT CACCTGTTGCCTAAACATGCACTGTTCCTAAAAGGTACAGTTTTTGCTCAAAATATATGAAAGGAAAGATAATCAGTTCTTAAAGTTTGG TATGCTAAATAAGCACCCAGGGAACTTACCTGCTCCACCTCACCCCAGAAATTGATTATTCAGGTCTGGAATATGGCTCAGGATTCTTAA TTTTCAACCAACACAATATAGAATCCTGTCAGTTATCCTTGGATCATTTGCTAAGTGATCTTGCAAAATCAAAACTCCTTTGAGACTATT TCATTTTCAGAAATATTTTAAAACTTGTTCAGAAACATCTTAAAACTTGTTAGCATATAGGAAAAGTACAATGCTTGGTGTAGGTAGGTT ATTATTTGGTCATTTCCCTCAAACCATCCAGACAAGCCACTCTTCTACCACAAGCTGGTAGAAATCCTTAGGCACCTTTCTGCTTCTGCA CTGCTATCACTTTCAGGTGTCTAAGGCTTCTGGAAGGCTGTTGTCATAACCTGGAGCCATACACCTAATGTACGTCTGGGGAAAGGACAC CAATTAAAGAATCTAGAGCTAGGATGATGTTACATAAGACAGGGCACAATGGAGATGGACTCTGGATCCCTGCATCTGAAAGAAAAAGGC AAGAAAATGCAGGGCAGGGAAAATCCTGAAGGTCTTCACTGACCATGAATTAAAATCCTAATTGACAGTTTTACAAACAAAAACCCTCGT TTTAGTACTTGTGTTGTTTTTGTTTCTGTTTTAACAAGCTTAGATTTATTATTGTGCCTTTTATGGAAGATGAGGAAGAAATAGGAAAGC AGTAAAATGAACAATGAGAATCTGTTACCCAAACTGATATAAACTCCCTCAGAAAGAAAGATACTACTCCCTAATCCTGGAAGTGTTAAG TGGCAATAATGATCAAATGTTGTAAAGGGGATTGTTACTACAGCTAATATGAAATGGGAGGCTGGACTAAATCTAACCTTTCTACCCTTG ATTTCAATTCTAAAAGGACACGTAATACCATTGCAGAAAGAAAAGACAGTTCCAAATGATAAATTTTAGAGTTGTTTTGCTAGGATGCAA GAGAAATTGGATAAGTGGACCACTCATACGTTGCTGGTGAGATATGAAATAGTAGAGCCACTGTGGAAAATATTCTTGGCAGTTTCTTAT AAAACTAAACATACATTTAACATATAACTGGCATTTGTACTACTTGACAGTTATCCCTGAGAAGTTAAAACTTAACATTCACAAATGTTA CATAGCACCTTCATTTATAATAGCCAAAACCCGGAAACAACCTGGATGTCCTTCAAAAAGAGTGAATGGTTTAGTATGTCCACACCATGG AATACTAAATAGTAATATGAAGGAACAAACTACTGATACATGTAACAAATTGCATGGACCTCAAGGGAATTATGCTTGGGTGGTTTGGGG GGACAATCCTAAAGTTTTACACACTGTATGATTCTGTTTTTGTAACATTCTTAAATAATAAAGCTATAGAGATGGGAAACAAGATTCGTG GTTGCCAGGTCTTGGGACTGAAGGGAAGGAGAATGTGGCTATAAAGGGAGCCTTGTGGTGGAAAAGTTCTGTAGTTTGATTGTGGTGATT ACATAAATATACATGTGAAATGTTAGAAGTATTTATAGCTGAAACATATTAGTATGTTGGTATATACATATTTCTGACTAATTAATTTCG CCATGTTGCCCAGGCTGGTCTCGAACTCCTAAGCTCAAGTGATGTGCCCGCCTCAACTTCCCAAGTGCTGAGATTACAGGCGTGAGCCAC CATGTCCGGCCTGTTTTTTCCTATGCATGCATAATTACGATCAAGTTTAATTTGTAATTAGGCACATTAAGAGATTAACAATAGCTAACA >In-frame_ENST00000271526_ENST00000370282_TCGA-ET-A40S-01A_PRCC_chr1_156738031_+_TMED5_chr1_93625783_length(amino acids)=322AA_start in transcript=272_stop in transcript=1240 MSLVAYASSDESEPDEAEPEPEEEEAVAPTSGPALGGLFASLPAPKGPALLPPPPQMLAPAFPPPLLLPPPTGDPRLQPPPPLPFGLGGF PPPPGVSPAEAAGVGEGLGLGLPSPRGPGLNLPPPIGGAGPPLGLPKPKKRKEPVKIAAPELHKGDVLDGAGLDIDFHLASPEGKTLVFE QRKSDGVHTVETEVGDYMFCFDNTFSTISEKVIFFELILDNMGEQAQEQEDWKKYITGTDILDMKLEDILESINSIKSRLSKSGHIQTLL -------------------------------------------------------------- >In-frame_ENST00000353233_ENST00000370282_TCGA-ET-A40S-01A_PRCC_chr1_156738031_+_TMED5_chr1_93625783_length(transcript)=6115nt_BP=686nt TTGCCCGGGACTAGGAGCTTAAGTGAAGAGGTACGCCTTGTTCGGTGGAAATCAGCCGTAGCCATGAGTTTCTGCCGGGGCTAGCCCTAG AGTACGGAGCAGGCGGACTTTTCGGTTCCCCGCCCCGCCAGGTGGCGGGGCCTACTAGGCCTCCGGGCATCCCCGGTCTCAAGTAGGCCT CATCTGCCGGCAAGGGCGCCCGAAACGCGGGAGGCGCCATGTCGCTGGTTGCTTACGCCAGCAGCGATGAGAGCGAGCCGGATGAGGCTG AGCCCGAGCCGGAGGAAGAGGAGGCGGTGGCTCCTACATCTGGGCCCGCTTTAGGGGGCTTGTTCGCTTCTCTCCCTGCGCCCAAGGGTC CGGCCTTGCTGCCTCCGCCCCCTCAGATGCTGGCGCCAGCCTTTCCCCCGCCGCTGTTGCTTCCCCCACCCACCGGAGACCCCAGGCTTC AGCCTCCTCCCCCCTTGCCCTTCGGCCTGGGAGGCTTCCCCCCACCTCCAGGCGTGAGCCCGGCTGAAGCGGCGGGAGTTGGGGAGGGAC TGGGATTGGGGTTGCCCTCGCCCCGAGGCCCTGGCCTCAATCTGCCCCCTCCAATTGGCGGTGCCGGTCCCCCGCTGGGGCTTCCCAAGC CAAAGAAGAGGAAAGAGCCCGTGAAGATCGCGGCGCCGGAGTTGCATAAGGGAGATGTTTTAGATGGAGCAGGATTAGATATTGATTTCC ATCTTGCCTCTCCAGAAGGCAAAACCTTAGTTTTTGAACAAAGAAAATCAGATGGAGTTCACACTGTAGAGACTGAAGTTGGTGATTACA TGTTCTGCTTTGACAATACATTCAGCACCATTTCTGAGAAGGTGATTTTCTTTGAATTAATCCTGGATAATATGGGAGAACAGGCACAAG AACAAGAAGATTGGAAGAAATATATTACTGGCACAGATATATTGGATATGAAACTGGAAGACATCCTGGAATCCATCAACAGCATCAAGT CCAGACTAAGCAAAAGTGGGCACATACAAACTCTGCTTAGAGCATTTGAAGCTCGTGATCGAAACATACAAGAAAGCAACTTTGATAGAG TCAATTTCTGGTCTATGGTTAATTTAGTGGTCATGGTGGTGGTGTCAGCCATTCAAGTTTATATGCTGAAGAGTCTGTTTGAAGATAAGA GGAAAAGTAGAACTTAAAACTCCAAACTAGAGTACGTAACATTGAAAAATGAGGCATAAAAATGCAATAAACTGTTACAGTCAAGACCAT TAATGGTCTTCTCCAAAATATTTTGAGATATAAAAGTAGGAAACAGGTATAATTTTAATGTGAAAATTAAGTCTTCACTTTCTGTGCAAG TAATCCTGCTGATCCAGTTGTACTTAAGTGTGTAACAGGAATATTTTGCAGAATATAGGTTTAACTGAATGAAGCCATATTAATAACTGC ATTTTCCTAACTTTGAAAAATTTTGCAAATGTCTTAGGTGATTTAAATAAATGAGTATTGGGCCTAATTGCAACACCAGTCTGTTTTTAA CAGGTTCTATTACCCAGAACTTTTTTGTAAATGCGGCAGTTACAAATTAACTGTGGAAGTTTTCAGTTTTAAGTTATAAATCACCTGAGA ATTACCTAATGATGGATTGAATAAATCTTTAGACTACAAAAGCCCAACTTTTCTCTATTTACATATGCATCTCTCCTATAATGTAAATAG AATAATAGCTTTGAAATACAATTAGGTTTTTGAGATTTTTATAACCAAATACATTTCAGTGTAACATATTAGCAGAAAGCATTAGTCTTT GTACTTTGCTTACATTCCCAAAAGCTGACATTTTCACGATTCTTAAAAACACAAAGTTACACTTACTAAAATTAGGACATGTTTTCTCTT TGAAATGAAGAATATAGTTTAAAAGCTTCCTCCTCCATAGGGACACATTTTCTCTAACCCTTAACTAAAGTGTAGGATTTTAAAATTAAA TGTGAGGTAAAATAAGTTTATTTTTAATAGTATCTGTCAAGTTAATATCTGTCAACAGTTAATAATCATGTTATGTTAATTTTAACATGA TTGCTGACTTGGATAATTCATTATTACCAGCAGTTATGAAGGAAATATTGCTAAAATGATCTGGGCCTACCATAAATAAATATCTCCTTT TCTGAGCTCTAAGAATTATCAGAAACAGGAAAGAATTTAGAAAAACTTGAGAAAACCTAATCCAAAATAAAATTCACTTAAGTAGAACTA TAAATAAATATCTAGAATCTGACTGGCTCATCATGACATCCTACTCATAACATAAATCAAAGGAGATGATTAATTTCCAGTTAGCTGGAA GAAACTTTGGCTGTAGGTTTTTATTTTCTACAAGAATTCTGGTTTGAATTATTTTTGTAAGCAGGTACATTTTATAAAATGTAAGCCCTA CTGTAAGGTTTAGCACTGGGTGTACATATTTATTAAAAATTTTTATTATAACAACTTTTATTAAAATGGCCTTTCTGAACACTTTATTTA TTGATGTTGAAGTAAGGATTAGAAACATAGACTCCCAAGTTTTAAACACCTAAATGTGAATAACCCATATATACAACAAAGTTTCTGCCA TCTAGCTTTTTGAAGTCTATGGGGGTCTTACTCAAGTACTAGTAATTTAACTTCATCATGAATGAACTATAATTTTTAAGTTATGCCCAT TTATAACGTTGTTTATGACTACATTGTGAGTTAGAAACAAACTTAAAATTTGGGGTATAGAACCCCTCAACAGGTTAGTAATGCTGGAAT TCTTGATGAGCAATAATGATAACCAGAGAGTGATTTCATTTACACTCATAGTAGTATAAAAAGAGATACATTTCCCTCTTAGGCCCCTGG GAGAAGAGCAGCTTAGATTTCCCTACTGGCAAGGTTTTTAAAAATGAGGTAAATGCCGTATATGATCAATTACCTTAATTGGCCAAGAAA ATGCTTCAGGTGTCTAGGGGTATCCTCTGCAACACTTGCAGAACAAAGGTCAATAAGATCCTTGCCTATGAATACCCCTCCCTTTTGCGC TGTTAAATTTGCAATGAGAAGCAAATTTACAGTACCATAACTAATAAAGCAGGGTACAGATATAAACTACTGCATCTTTTCTATAAAACT GTGATTAAGAATTCTACCTCTCCTGTATGGCTGTTACTGTACTGTACTCTCTGACTCCTTACCTAACAATGAATTTGTTACATAATCTTC TACATGTATGATTTGTGCCACTGATCTTAAACCTATGATTCAGTAACTTCTTACCATATAAAAACGATAATTGCTTTATTTGGAAAAGAA TTTAGGAATACTAAGGACAATTATTTTTATAGACAAAGTAAAAAGACAGATATTTAAGAGGCATAACCAAAAAAGCAAAACTTGTAAACA GAGTAAAAATCTTTAATATTTCTAAAGACATACTGTTTATCTGCTTCATATGCTTTTTTTAATTTCACTATTCCATTTCTAAATTAAAGT TATGCTAAATTGAGTAAGCTGTTTATCACTTAACAGCTCATTTTGTCTTTTTCAATATACAAATTTTAAAAATACTACAATATTTAACTA AGGCCCAACCGATTTCCATAATGTAGCAGTTACCGTGTTCACCTCACACTAAGGCCTAGAGTTTGCTCTGATATGCATTTGGATGATTAA TGTTATGCTGTTCTTTCATGTGAATGTCAAGACATGGAGGGTGTTTGTAATTTTATGGTAAAATTAATCCTTCTTACACATAATGGTGTC TTAAAATTGACAAAAAATGAGCACTTACAATTGTATGTCTCCTCAAATGAAAATTCTTTATCTGAAATTTTAAAAGACATTGATTCCACA TGTAAGGATTTTTCATCTGAAGTACAATAATGCACAATCAGTGTTGCTCAAACTGCTTTATACTTATAAACAGCCATCTTAAATAAGCAA CGTATTGTGAGTACTGATATGTATATAATAAAAATTATCAAAGAAAATTAACTGCCAGTCATTTGTAAATGCTGTCTACTCCTGAAAGCC TTCCTTCATCTCTATTTAGTTAATAATGTGCTCTCTCCTCCTGTTTTGAAACCCCATAGCTCTCTACACCTCTTATTGTACATCACTCTA CTTTGCATTGGAGTTCTGTTTCTATATGTACTTATTCACCTGTTGCCTAAACATGCACTGTTCCTAAAAGGTACAGTTTTTGCTCAAAAT ATATGAAAGGAAAGATAATCAGTTCTTAAAGTTTGGTATGCTAAATAAGCACCCAGGGAACTTACCTGCTCCACCTCACCCCAGAAATTG ATTATTCAGGTCTGGAATATGGCTCAGGATTCTTAATTTTCAACCAACACAATATAGAATCCTGTCAGTTATCCTTGGATCATTTGCTAA GTGATCTTGCAAAATCAAAACTCCTTTGAGACTATTTCATTTTCAGAAATATTTTAAAACTTGTTCAGAAACATCTTAAAACTTGTTAGC ATATAGGAAAAGTACAATGCTTGGTGTAGGTAGGTTATTATTTGGTCATTTCCCTCAAACCATCCAGACAAGCCACTCTTCTACCACAAG CTGGTAGAAATCCTTAGGCACCTTTCTGCTTCTGCACTGCTATCACTTTCAGGTGTCTAAGGCTTCTGGAAGGCTGTTGTCATAACCTGG AGCCATACACCTAATGTACGTCTGGGGAAAGGACACCAATTAAAGAATCTAGAGCTAGGATGATGTTACATAAGACAGGGCACAATGGAG ATGGACTCTGGATCCCTGCATCTGAAAGAAAAAGGCAAGAAAATGCAGGGCAGGGAAAATCCTGAAGGTCTTCACTGACCATGAATTAAA ATCCTAATTGACAGTTTTACAAACAAAAACCCTCGTTTTAGTACTTGTGTTGTTTTTGTTTCTGTTTTAACAAGCTTAGATTTATTATTG TGCCTTTTATGGAAGATGAGGAAGAAATAGGAAAGCAGTAAAATGAACAATGAGAATCTGTTACCCAAACTGATATAAACTCCCTCAGAA AGAAAGATACTACTCCCTAATCCTGGAAGTGTTAAGTGGCAATAATGATCAAATGTTGTAAAGGGGATTGTTACTACAGCTAATATGAAA TGGGAGGCTGGACTAAATCTAACCTTTCTACCCTTGATTTCAATTCTAAAAGGACACGTAATACCATTGCAGAAAGAAAAGACAGTTCCA AATGATAAATTTTAGAGTTGTTTTGCTAGGATGCAAGAGAAATTGGATAAGTGGACCACTCATACGTTGCTGGTGAGATATGAAATAGTA GAGCCACTGTGGAAAATATTCTTGGCAGTTTCTTATAAAACTAAACATACATTTAACATATAACTGGCATTTGTACTACTTGACAGTTAT CCCTGAGAAGTTAAAACTTAACATTCACAAATGTTACATAGCACCTTCATTTATAATAGCCAAAACCCGGAAACAACCTGGATGTCCTTC AAAAAGAGTGAATGGTTTAGTATGTCCACACCATGGAATACTAAATAGTAATATGAAGGAACAAACTACTGATACATGTAACAAATTGCA TGGACCTCAAGGGAATTATGCTTGGGTGGTTTGGGGGGACAATCCTAAAGTTTTACACACTGTATGATTCTGTTTTTGTAACATTCTTAA ATAATAAAGCTATAGAGATGGGAAACAAGATTCGTGGTTGCCAGGTCTTGGGACTGAAGGGAAGGAGAATGTGGCTATAAAGGGAGCCTT GTGGTGGAAAAGTTCTGTAGTTTGATTGTGGTGATTACATAAATATACATGTGAAATGTTAGAAGTATTTATAGCTGAAACATATTAGTA TGTTGGTATATACATATTTCTGACTAATTAATTTCGCCATGTTGCCCAGGCTGGTCTCGAACTCCTAAGCTCAAGTGATGTGCCCGCCTC AACTTCCCAAGTGCTGAGATTACAGGCGTGAGCCACCATGTCCGGCCTGTTTTTTCCTATGCATGCATAATTACGATCAAGTTTAATTTG >In-frame_ENST00000353233_ENST00000370282_TCGA-ET-A40S-01A_PRCC_chr1_156738031_+_TMED5_chr1_93625783_length(amino acids)=322AA_start in transcript=218_stop in transcript=1186 MSLVAYASSDESEPDEAEPEPEEEEAVAPTSGPALGGLFASLPAPKGPALLPPPPQMLAPAFPPPLLLPPPTGDPRLQPPPPLPFGLGGF PPPPGVSPAEAAGVGEGLGLGLPSPRGPGLNLPPPIGGAGPPLGLPKPKKRKEPVKIAAPELHKGDVLDGAGLDIDFHLASPEGKTLVFE QRKSDGVHTVETEVGDYMFCFDNTFSTISEKVIFFELILDNMGEQAQEQEDWKKYITGTDILDMKLEDILESINSIKSRLSKSGHIQTLL -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for PRCC-TMED5 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for PRCC-TMED5 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for PRCC-TMED5 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | PRCC | C4518356 | MiT family translocation renal cell carcinoma | 3 | ORPHANET |